Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats (original) (raw)

References

1. Reaven GM, Bernstein R, Davis B, Olefsky JM: Non-ketotic diabetes mellitus: Insulin deficiency or insulin resistance? Am J Med 60: 80–88, 1976
   PubMed Google Scholar
2. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: A balanced overview. Diabetes Care 15: 318–368, 1992
   PubMed Google Scholar
3. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase activity in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78: 471–477, 1994
   PubMed Google Scholar
4. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 321: 337–343, 1989
   PubMed Google Scholar
5. Torgan CE, Brozinick JT Jr, Banks EA, Cortez MY, Wilcox RE, Ivy K: Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. Am J Physiol 264: E373–E379, 1993
   PubMed Google Scholar
6. Kasuga M, Karisson FA, Kahn CR: Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215: 185–187, 1982
   PubMed Google Scholar
7. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR: Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298: 667–669, 1982
   PubMed Google Scholar
8. Rothenberg PL, Land WS, Karasik A, Backer J, White MF, Kahn CR: Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266: 8302–8311, 1991
   PubMed Google Scholar
9. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA: Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45: 721–732, 1986
   PubMed Google Scholar
10. Arner P, Pollare T, Lithell H, Livingston JN: Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 30: 437–440, 1987
    PubMed Google Scholar
11. Caro JF, Sinha MK, Raju SM, Ittoo O, Pories M, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337, 1987
    PubMed Google Scholar
12. Obermaier-Kusser B, White MF, Pongratz DE, Su Z, Ermel B, Muhlbacher C, Haring HU: A defective intramolecullar autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem 264: 9497–9504,1989
    PubMed Google Scholar
13. White MF, Shoelson SE, Keutmann H, Kahn CR: A cascade of tyrosine autophosphorylation in the β-subunit activates the insulin receptor. J Biol Chem 263: 2969–2980, 1988
    PubMed Google Scholar
14. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koskland DE Jr: Protein kinase C directly phosphorylated the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 83: 5822–5824, 1986
    PubMed Google Scholar
15. Takayama S, White MF, Kahn CR: Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263: 3440–3447, 1988
    PubMed Google Scholar
16. Haring HU, Kirsch D, Obermaier B, Ermel B, Machicao F: Reduced tyrosine kinase activity of insulin receptor isolated from rat adipocyte rendered insulin resistant by catecholamine treatment in vitro. Biochem J 234: 59–66, 1996
    Google Scholar
17. Kamps MP: (1991) Generation and use of anti-phosphotyrosine antibodies for immunoblotting. In: T. Hunter, B.M. Sefton (eds). Methods in Enzymology. Vol 201, Academic Press, San Diego, 1991, pp 101–110
    Google Scholar
18. Dohm GL, Kasperek GJ, Tapscott EB, Beecher GB: Effect of exercise on synthesis and degradation of muscle protein. Biochem J 188: 255–262, 1980
    PubMed Google Scholar
19. Chang PY, Goodyear LJ, Benecke H, Markuns JS, Moller DE: Impaired insulin signaling in skeletal muscle from transgenic mice expressing kinase deficient insulin receptors. J Biol Chem 270: 12593–12600, 1995
    PubMed Google Scholar
20. Sherman WM, Friedman JE, Gao JP, Reed MJ, Elton CW, Dohm GL: Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat. Med Sci Sports Exer 25: 341–348, 1993
    Google Scholar
21. Brozinick JT Jr, Etgen GJ Jr, Yaspelkis BB III, Ivy K: Glucose uptake and GLUT-4 protein distribution in skeletal muscle of the obese Zucker rats. Am J Physiol 267: R236–R243,1994
    PubMed Google Scholar
22. Ahmad F, Considine RV, Goldstein BJ: Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest 95: 2806–2812, 1995
    PubMed Google Scholar
23. Kulas DT, Zhang WR, Goldstein BJ, Furlanetto RW, Mooney RA: Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J Biol Chem 270: 2435–2438, 1995
    PubMed Google Scholar
24. Tanti JF, Gremeaux T, van Obberghen E, Le Marchand-Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269: 6051–6057, 1994
    PubMed Google Scholar
25. Hotamisligil GS, Peraidi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNFα-and obesity-induced insulin resistance. Science 271: 665–668, 1996
    PubMed Google Scholar
26. Haring HU, Kirsch D, Obermaier B, Ermel B, Machicao F: Tumor promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J Biol Chem 261: 3869–3875, 1996
    Google Scholar
27. Dunaif A, Xia J, Book CB, Schenker E, Tang Z: Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 96: 801–810, 1995
    PubMed Google Scholar
28. Pang DT, Sharma BR, Shafer JA, White MF, Kahn CR: Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin. J Biol Chem 260: 7131–7136, 1985
    PubMed Google Scholar
29. Iwama N, Watarai T, Kajimoto Y, Yamasaki Y, Yokoyama T, Kawamori R, Kamada T: Dephosphorylation of the insulin receptor partially restores the decreased autophosphorylation in streptozotocin induced diabetic rats. Diabetes Res 17: 25–32, 1991
    PubMed Google Scholar
30. Tavare JM, Zhang B, Ellis L, Roth RA: Insulin-stimulated serine and threonine phosphorylation of the human insulin receptor. J Biol Chem 266: 21804–21809, 1991
    PubMed Google Scholar
31. Donnelly R, Reed MJ, Azhar S, Reaven GM: Expression of the major isoenzyme of protein kinase-C in skeletal muscle, PKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135: 2369–2374, 1994
    PubMed Google Scholar
32. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ: Alteration in the expression and cellular localization of protein kinase C isozymes ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169–178, 1997
    PubMed Google Scholar
33. Avignon A, Yamada K, Zhou X, Spencer B, Cardona O, Saba-Siddique S, Galloway L, Standaert ML, Farese RV: Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakiwki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes 45: 1396–1404, 1996
    PubMed Google Scholar

Download references